{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:42:59Z","timestamp":1791434579376,"version":"4.3.3"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["80-83600-98-10190"],"award-info":[{"award-number":["80-83600-98-10190"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"General University Hospital","award":["64-165\/2012"],"award-info":[{"award-number":["64-165\/2012"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ejps.2017.05.026","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T09:32:04Z","timestamp":1494581524000},"page":"S90-S97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"S","title":["Model-based clinical dose optimization for phenobarbital in neonates: An illustration of the importance of data sharing and external validation"],"prefix":"10.1016","volume":"109","author":[{"given":"Swantje","family":"V\u00f6ller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Flint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo M.","family":"Stolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter L.J.","family":"Degraeuwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinno H.P.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Pokorna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Tibboel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherijne A.J.","family":"Knibbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejps.2017.05.026_bb0005","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jps.2600770910","article-title":"Autoinduction of phenobarbital elimination in the dog","volume":"77","author":"Abramson","year":"1988","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.05.026_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.46.120604.141059","article-title":"Regulation of drug-metabolizing enzymes and transporters in inflammation","volume":"46","author":"Aitken","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.ejps.2017.05.026_bb0015","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1590\/S0100-879X2003000600012","article-title":"Weight of preterm newborns during the first twelve weeks of life","volume":"36","author":"Anchieta","year":"2003","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"1","key":"10.1016\/j.ejps.2017.05.026_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-200645010-00001","article-title":"Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?","volume":"45","author":"Bjorkman","year":"2006","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.ejps.2017.05.026_bb0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/0883073808321056","article-title":"Neonatal seizures: treatment and treatment variability in 31 United States pediatric hospitals","volume":"24","author":"Blume","year":"2009","journal-title":"J. Child Neurol."},{"issue":"2","key":"10.1016\/j.ejps.2017.05.026_bb0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1651-2227.1978.tb16302.x","article-title":"Phenobarbital metabolism in adults and in newborn infants","volume":"67","author":"Boreus","year":"1978","journal-title":"Acta Paediatr. Scand."},{"issue":"9","key":"10.1016\/j.ejps.2017.05.026_bb0035","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/17512433.2016.1198256","article-title":"Children in clinical trials: towards evidence-based pediatric pharmacotherapy using pharmacokinetic-pharmacodynamic modeling","volume":"9","author":"Brussee","year":"2016","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.05.026_bb0040","article-title":"Allometric scaling of clearance in Paediatric patients: when does the magic of 0.75 fade?","volume":"10","author":"Calvier","year":"2016","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.ejps.2017.05.026_bb0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","article-title":"Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R","volume":"90","author":"Comets","year":"2008","journal-title":"Comput. Methods Prog. Biomed."},{"issue":"Suppl. 1","key":"10.1016\/j.ejps.2017.05.026_bb0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00228-009-0782-9","article-title":"The role of population PK-PD modelling in paediatric clinical research","volume":"67","author":"De Cock","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejps.2017.05.026_bb0055","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/jac\/dkt527","article-title":"Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonates","volume":"69","author":"De Cock","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.ejps.2017.05.026_bb0060","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1542\/peds.75.6.1061","article-title":"Safety of a higher loading dose of phenobarbital in the term newborn","volume":"75","author":"Donn","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejps.2017.05.026_bb0065","author":"Dutch National Children's Formulary"},{"issue":"5","key":"10.1016\/j.ejps.2017.05.026_bb0070","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1542\/peds.83.5.674","article-title":"Rapid sequential phenobarbital treatment of neonatal seizures","volume":"83","author":"Gilman","year":"1989","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.ejps.2017.05.026_bb0075","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000457062","article-title":"Neonatal population pharmacokinetics of phenobarbital derived from routine clinical data","volume":"8","author":"Grasela","year":"1985","journal-title":"Dev. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.ejps.2017.05.026_bb0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00607431","article-title":"Pharmacokinetics of phenobarbital in childhood","volume":"12","author":"Heimann","year":"1977","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5\u20136","key":"10.1016\/j.ejps.2017.05.026_bb0085","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.drudis.2008.11.004","article-title":"Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling","volume":"14","author":"Ince","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2017.05.026_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2013.24","article-title":"Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose","volume":"2","author":"Keizer","year":"2013","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2017.05.026_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2011.02.056","article-title":"Individualized dosing regimens in children based on population PKPD modelling: are we ready for it?","volume":"415","author":"Knibbe","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2017.05.026_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425255.2011.539201","article-title":"Advances in paediatric pharmacokinetics","volume":"7","author":"Knibbe","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"4","key":"10.1016\/j.ejps.2017.05.026_bb0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11095-010-0333-1","article-title":"Systematic evaluation of the descriptive and predictive performance of paediatric morphine population models","volume":"28","author":"Krekels","year":"2011","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.ejps.2017.05.026_bb0110","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1517\/17425255.2015.1065815","article-title":"Pediatric pharmacology: current efforts and future goals to improve clinical practice","volume":"11","author":"Krekels","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"3","key":"10.1016\/j.ejps.2017.05.026_bb0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","article-title":"PsN-toolkit\u2014a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM","volume":"79","author":"Lindbom","year":"2005","journal-title":"Comput. Methods Prog. Biomed."},{"issue":"4","key":"10.1016\/j.ejps.2017.05.026_bb0120","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/fcp.12042","article-title":"Pharmacokinetics and absolute bioavailability of phenobarbital in neonates and young infants, a population pharmacokinetic modelling approach","volume":"28","author":"Marsot","year":"2014","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.ejps.2017.05.026_bb0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/j.1552-4604.1982.tb02662.x","article-title":"Phenobarbital pharmacokinetics and bioavailability in adults","volume":"22","author":"Nelson","year":"1982","journal-title":"J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.ejps.2017.05.026_bb0130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/adc.57.9.653","article-title":"Phenobarbitone dosage in neonatal convulsions","volume":"57","author":"Ouvrier","year":"1982","journal-title":"Arch. Dis. Child."},{"issue":"8","key":"10.1016\/j.ejps.2017.05.026_bb0135","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00381-013-2094-8","article-title":"Can we safely administer the recommended dose of phenobarbital in very low birth weight infants?","volume":"29","author":"Oztekin","year":"2013","journal-title":"Childs Nerv. Syst."},{"issue":"1","key":"10.1016\/j.ejps.2017.05.026_bb0140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/1573397111666151026223914","article-title":"Clinical pharmacology of phenobarbital in neonates: effects, metabolism and pharmacokinetics","volume":"12","author":"Pacifici","year":"2016","journal-title":"Curr. Pediatr. Rev."},{"issue":"7","key":"10.1016\/j.ejps.2017.05.026_bb0145","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199908123410704","article-title":"Phenobarbital compared with phenytoin for the treatment of neonatal seizures","volume":"341","author":"Painter","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"39","key":"10.1016\/j.ejps.2017.05.026_bb0150","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.2174\/1381612821666150901110929","article-title":"The impact of hypothermia on the pharmacokinetics of drugs used in neonates and young infants","volume":"21","author":"Pokorna","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.ejps.2017.05.026_bb0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00019052-200304000-00010","article-title":"Neonatal seizures and their treatment","volume":"16","author":"Rennie","year":"2003","journal-title":"Curr. Opin. Neurol."},{"issue":"4","key":"10.1016\/j.ejps.2017.05.026_bb0160","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/FTD.0000000000000043","article-title":"Comparability and imprecision of 8 frequently used commercially available immunoassays for therapeutic drug monitoring","volume":"36","author":"Shipkova","year":"2014","journal-title":"Ther. Drug Monit."},{"issue":"3","key":"10.1016\/j.ejps.2017.05.026_bb0165","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00007691-200206000-00017","article-title":"Evaluation of fluorescence polarization assays for measuring valproic acid, phenytoin, carbamazepine and phenobarbital in serum","volume":"24","author":"Steijns","year":"2002","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2017.05.026_bb0170","article-title":"Challenging expected patterns of weight loss in full-term breastfeeding neonates born by cesarean","volume":"21","author":"Thulier","year":"2016","journal-title":"J. Obstet. Gynecol. Neonatal. Nurs."},{"issue":"1","key":"10.1016\/j.ejps.2017.05.026_bb0175","first-page":"31","article-title":"A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures","volume":"17","author":"Tulloch","year":"2012","journal-title":"J. Pediatr. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.ejps.2017.05.026_bb0180","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00228-010-0811-8","article-title":"Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD)","volume":"66","author":"Ward","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejps.2017.05.026_bb0185","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1203\/00006450-200110000-00005","article-title":"Prolonged seizures exacerbate perinatal hypoxic-ischemic brain damage","volume":"50","author":"Wirrell","year":"2001","journal-title":"Pediatr. Res."},{"issue":"6","key":"10.1016\/j.ejps.2017.05.026_bb0190","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2710.2010.01220.x","article-title":"Population pharmacokinetics of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants: an update","volume":"36","author":"Yukawa","year":"2011","journal-title":"J. Clin. Pharm. Ther."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717302543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717302543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T14:30:21Z","timestamp":1659018621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717302543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":38,"alternative-id":["S0928098717302543"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.05.026","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Model-based clinical dose optimization for phenobarbital in neonates: An illustration of the importance of data sharing and external validation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}